Kemal Bakır

732 total citations
62 papers, 533 citations indexed

About

Kemal Bakır is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Kemal Bakır has authored 62 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 25 papers in Surgery and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Kemal Bakır's work include Lung Cancer Treatments and Mutations (6 papers), Occupational and environmental lung diseases (5 papers) and Pleural and Pulmonary Diseases (5 papers). Kemal Bakır is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Occupational and environmental lung diseases (5 papers) and Pleural and Pulmonary Diseases (5 papers). Kemal Bakır collaborates with scholars based in Türkiye, United States and Germany. Kemal Bakır's co-authors include Kemal Sarıca, Ahmet Erbağcı, Faruk Yağcı, N. Emrah Koçer, Levent Elbeylı, Bülent Tunçözgür, Muzaffer Kanlı́kama, Sakıp Erturhan, Cengiz Durucu and Haşim Üstünsoy and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Radiology and Respiratory Medicine.

In The Last Decade

Kemal Bakır

56 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kemal Bakır Türkiye 12 231 162 96 78 64 62 533
Ayşegül Cansu Türkiye 14 116 0.5× 165 1.0× 57 0.6× 42 0.5× 67 1.0× 44 702
Mehmet Akın Türkiye 16 121 0.5× 297 1.8× 44 0.5× 149 1.9× 62 1.0× 78 770
Scott J. Schurman United States 13 159 0.7× 109 0.7× 100 1.0× 27 0.3× 109 1.7× 26 530
G Rifle France 16 165 0.7× 107 0.7× 55 0.6× 44 0.6× 87 1.4× 70 580
Ayad Ahmad Mohammed Iraq 12 92 0.4× 223 1.4× 137 1.4× 76 1.0× 36 0.6× 89 477
Gungor Karayalcin United States 18 126 0.5× 124 0.8× 122 1.3× 97 1.2× 53 0.8× 63 833
Maria Giuliano Italy 14 189 0.8× 212 1.3× 100 1.0× 79 1.0× 148 2.3× 27 651
Deirdre O’Hanlon Ireland 17 163 0.7× 503 3.1× 60 0.6× 128 1.6× 161 2.5× 79 902
R. Reif Israel 12 139 0.6× 186 1.1× 64 0.7× 79 1.0× 66 1.0× 32 430
K.N. Lai Hong Kong 20 162 0.7× 128 0.8× 130 1.4× 61 0.8× 165 2.6× 34 982

Countries citing papers authored by Kemal Bakır

Since Specialization
Citations

This map shows the geographic impact of Kemal Bakır's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemal Bakır with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemal Bakır more than expected).

Fields of papers citing papers by Kemal Bakır

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemal Bakır. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemal Bakır. The network helps show where Kemal Bakır may publish in the future.

Co-authorship network of co-authors of Kemal Bakır

This figure shows the co-authorship network connecting the top 25 collaborators of Kemal Bakır. A scholar is included among the top collaborators of Kemal Bakır based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemal Bakır. Kemal Bakır is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bozdağ, Zehra, et al.. (2019). Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?. Pathology & Oncology Research. 26(3). 1651–1656. 2 indexed citations
2.
Elboğa, Umut, et al.. (2014). A rare tumor: tracheal Ewing’s sarcoma. Wiener klinische Wochenschrift. 126(9-10). 259–260. 5 indexed citations
3.
Etıt, Demet, Kemal Bakır, Fulya Çakalağaoğlu, et al.. (2013). Interobserver agreement in salivary gland neoplasms by telepathology: An analysis of 47 cases.. PubMed. 35(2). 114–20. 5 indexed citations
4.
Çelenk, Fatih, Cengiz Durucu, Elif Baysal, et al.. (2013). Management of Upper Aerodigestive Tract Amyloidosis. Annals of Otology Rhinology & Laryngology. 122(8). 535–540. 9 indexed citations
5.
Pehlivan, Yavuz, İbrahim Halil Türkbeyler, Alper Sevinç, et al.. (2011). Possible anti-metastatic effect of Iloprost in a patient with systemic sclerosis with lung cancer: a case study. Rheumatology International. 32(5). 1437–1441. 6 indexed citations
6.
Bağlam, Tekin, et al.. (2011). Giant Pleomorphic Adenoma of the Nasal Septum. Indian Journal of Otolaryngology and Head & Neck Surgery. 63(4). 393–395. 13 indexed citations
7.
Bağlam, Tekin, Mehmet Kalender, Cengiz Durucu, et al.. (2009). Alveolar Soft Part Sarcoma of the Tongue. Journal of Craniofacial Surgery. 20(6). 2160–2162. 11 indexed citations
8.
Bakır, Kemal, et al.. (2009). Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?. Pathology - Research and Practice. 205(11). 749–752. 11 indexed citations
10.
Mumbuç, Semih, et al.. (2008). Hamartoma of the Larynx Causing Nonspecific Symptoms in the False Vocal Fold: Original Image. Turkiye Klinikleri Tip Bilimleri Dergisi. 28(2). 252–254. 1 indexed citations
11.
Tunçözgür, Bülent, et al.. (2008). The reliability of mediastinoscopic frozen sections in deciding on oncological surgery in bronchogenic carcinoma. Advances in Therapy. 25(5). 488–495. 6 indexed citations
12.
Üstünsoy, Haşim, et al.. (2007). Is Chlamydia Pneumoniae a Risk Factor for Peripheral Atherosclerosis?. Asian Cardiovascular and Thoracic Annals. 15(1). 9–13. 6 indexed citations
13.
Sarıca, Kemal, et al.. (2004). Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria. Urological Research. 32(4). 271–277. 21 indexed citations
14.
Üstünsoy, Haşim, et al.. (2002). The inhibition of pro-inflammatory cytokines with pentoxifylline in the cardiopulmunary bypass lung. Respiratory Medicine. 96(4). 275–279. 6 indexed citations
15.
Yılmaz, Mehmet, et al.. (2002). Efficiacy of Methylprednisolone in Acute Experimental Cauda Equina Injury. Acta Neurochirurgica. 144(8). 817–821. 9 indexed citations
16.
Okan, Vahap, et al.. (2002). BERNARD‐SOULIER SYNDROME IN A TURKISH FAMILY. International Journal of Clinical Practice. 56(7). 546–548. 3 indexed citations
17.
Üstünsoy, Haşim, et al.. (2001). Antioxidant effects of pentoxiflline on the ischemia reperfusion and reexpansion injury of the lung. European Journal of Therapeutics. 12(1). 1–4. 1 indexed citations
18.
Karakök, Metin, et al.. (2001). AgNOR/P53 expression compared with different grades in bladder carcinoma. International Urology and Nephrology. 33(2). 353–355. 3 indexed citations
19.
Sarıca, Kemal, et al.. (1999). Limitation of Shockwave-Induced Enhanced Crystal Deposition in Traumatized Tissue by Verapamil in Rabbit Model. Journal of Endourology. 13(5). 343–347. 11 indexed citations
20.
Sarıca, Kemal, et al.. (1999). Unilateral Testicular Torsion: Protective Effect of Verapamil on Contralateral Testicular Histology. Urologia Internationalis. 62(3). 159–163. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026